- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, September 15, 2023
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in the Washington Examiner referenced a study published in the July 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “Projected US Savings From Biosimilars, 2021-2025,” found that using biosimilars from 2021 to 2025 had a projected savings of $38.4 billion, with a upper-bound estimate of $124.5 billion.
An article by the American Council on Science and Health referenced an article published on AJMC.com, the website of AJMC. The article, “Study Finds Prescription Drug Monitoring Programs Ineffective at Curbing Overdoses,” reported study findings that prescription drug monitoring programs were ineffective in tackling the nation’s drug problem.
An article from StartUp Health referenced a contributor article published on AJMC.com. The article, “Contributor: Medication Adherence is Not a Zero-Sum Game,” discussed how 50% of Americans who were tasked with a long-term medical regimen were not able to keep up with it.
An article from Health Digest referenced an article published on AJMC.com. The article, “Healthcare Trust Has Hit an All-Time Low, According to Report,” covered findings that trust in the health care system was 68 out of 100 in those surveyed, which was the lowest level in more than a decade.
Age-Related Disparities in Long-Term Outcomes for ER+, HER2– Breast Cancer
November 23rd 2024Younger women with estrogen receptor (ER)–positive, HER2-negative breast cancer have significantly worse long-term outcomes, including higher rates of recurrence and metastasis, compared with older women.
Read More
